Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs1126809

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr11:89284793 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
G>A
Variation Type
SNV Single Nucleotide Variation
Frequency
A=0.172492 (45657/264690, TOPMED)
A=0.176444 (44164/250300, GnomAD_exome)
A=0.180942 (25261/139608, GnomAD) (+ 20 more)
A=0.176973 (21333/120544, ExAC)
A=0.25926 (22292/85982, ALFA)
A=0.00004 (1/28258, 14KJPN)
A=0.0820 (525/6404, 1000G_30x)
A=0.0813 (407/5008, 1000G)
A=0.2916 (1124/3854, ALSPAC)
A=0.2853 (1058/3708, TWINSUK)
A=0.0007 (2/2922, KOREAN)
A=0.2213 (251/1134, Daghestan)
A=0.249 (249/998, GoNL)
A=0.008 (6/792, PRJEB37584)
A=0.235 (141/600, NorthernSweden)
A=0.208 (111/534, MGP)
A=0.080 (26/326, HapMap)
A=0.178 (54/304, FINRISK)
A=0.074 (16/216, Qatari)
G=0.48 (42/88, SGDP_PRJ)
A=0.34 (22/64, Ancient Sardinia)
G=0.5 (5/10, Siberian)
A=0.5 (5/10, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
TYR : Missense Variant
Publications
47 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20230706150541
Population Group Sample Size Ref Allele Alt Allele
Total Global 86070 G=0.74066 A=0.25934
European Sub 71088 G=0.72362 A=0.27638
African Sub 3688 G=0.9287 A=0.0713
African Others Sub 124 G=0.976 A=0.024
African American Sub 3564 G=0.9270 A=0.0730
Asian Sub 194 G=0.995 A=0.005
East Asian Sub 112 G=1.000 A=0.000
Other Asian Sub 82 G=0.99 A=0.01
Latin American 1 Sub 500 G=0.864 A=0.136
Latin American 2 Sub 648 G=0.872 A=0.128
South Asian Sub 98 G=0.96 A=0.04
Other Sub 9854 G=0.7712 A=0.2288


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 G=0.827508 A=0.172492
gnomAD - Exomes Global Study-wide 250300 G=0.823556 A=0.176444
gnomAD - Exomes European Sub 134582 G=0.744706 A=0.255294
gnomAD - Exomes Asian Sub 48988 G=0.96093 A=0.03907
gnomAD - Exomes American Sub 34404 G=0.89763 A=0.10237
gnomAD - Exomes African Sub 16174 G=0.95616 A=0.04384
gnomAD - Exomes Ashkenazi Jewish Sub 10060 G=0.76173 A=0.23827
gnomAD - Exomes Other Sub 6092 G=0.7925 A=0.2075
gnomAD - Genomes Global Study-wide 139608 G=0.819058 A=0.180942
gnomAD - Genomes European Sub 75632 G=0.73954 A=0.26046
gnomAD - Genomes African Sub 41882 G=0.94807 A=0.05193
gnomAD - Genomes American Sub 13558 G=0.83692 A=0.16308
gnomAD - Genomes Ashkenazi Jewish Sub 3310 G=0.7631 A=0.2369
gnomAD - Genomes East Asian Sub 3082 G=0.9990 A=0.0010
gnomAD - Genomes Other Sub 2144 G=0.8186 A=0.1814
ExAC Global Study-wide 120544 G=0.823027 A=0.176973
ExAC Europe Sub 73000 G=0.74425 A=0.25575
ExAC Asian Sub 25118 G=0.96007 A=0.03993
ExAC American Sub 11342 G=0.90839 A=0.09161
ExAC African Sub 10180 G=0.95373 A=0.04627
ExAC Other Sub 904 G=0.834 A=0.166
Allele Frequency Aggregator Total Global 85982 G=0.74074 A=0.25926
Allele Frequency Aggregator European Sub 71016 G=0.72368 A=0.27632
Allele Frequency Aggregator Other Sub 9838 G=0.7713 A=0.2287
Allele Frequency Aggregator African Sub 3688 G=0.9287 A=0.0713
Allele Frequency Aggregator Latin American 2 Sub 648 G=0.872 A=0.128
Allele Frequency Aggregator Latin American 1 Sub 500 G=0.864 A=0.136
Allele Frequency Aggregator Asian Sub 194 G=0.995 A=0.005
Allele Frequency Aggregator South Asian Sub 98 G=0.96 A=0.04
14KJPN JAPANESE Study-wide 28258 G=0.99996 A=0.00004
1000Genomes_30x Global Study-wide 6404 G=0.9180 A=0.0820
1000Genomes_30x African Sub 1786 G=0.9916 A=0.0084
1000Genomes_30x Europe Sub 1266 G=0.7457 A=0.2543
1000Genomes_30x South Asian Sub 1202 G=0.9451 A=0.0549
1000Genomes_30x East Asian Sub 1170 G=0.9991 A=0.0009
1000Genomes_30x American Sub 980 G=0.877 A=0.123
1000Genomes Global Study-wide 5008 G=0.9187 A=0.0813
1000Genomes African Sub 1322 G=0.9909 A=0.0091
1000Genomes East Asian Sub 1008 G=0.9990 A=0.0010
1000Genomes Europe Sub 1006 G=0.7475 A=0.2525
1000Genomes South Asian Sub 978 G=0.946 A=0.054
1000Genomes American Sub 694 G=0.875 A=0.125
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 G=0.7084 A=0.2916
UK 10K study - Twins TWIN COHORT Study-wide 3708 G=0.7147 A=0.2853
KOREAN population from KRGDB KOREAN Study-wide 2922 G=0.9993 A=0.0007
Genome-wide autozygosity in Daghestan Global Study-wide 1134 G=0.7787 A=0.2213
Genome-wide autozygosity in Daghestan Daghestan Sub 626 G=0.730 A=0.270
Genome-wide autozygosity in Daghestan Near_East Sub 144 G=0.757 A=0.243
Genome-wide autozygosity in Daghestan Central Asia Sub 122 G=0.877 A=0.123
Genome-wide autozygosity in Daghestan Europe Sub 108 G=0.759 A=0.241
Genome-wide autozygosity in Daghestan South Asian Sub 98 G=1.00 A=0.00
Genome-wide autozygosity in Daghestan Caucasus Sub 36 G=0.83 A=0.17
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 G=0.751 A=0.249
CNV burdens in cranial meningiomas Global Study-wide 792 G=0.992 A=0.008
CNV burdens in cranial meningiomas CRM Sub 792 G=0.992 A=0.008
Northern Sweden ACPOP Study-wide 600 G=0.765 A=0.235
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 G=0.792 A=0.208
HapMap Global Study-wide 326 G=0.920 A=0.080
HapMap American Sub 120 G=0.783 A=0.217
HapMap African Sub 118 G=1.000 A=0.000
HapMap Asian Sub 88 G=1.00 A=0.00
FINRISK Finnish from FINRISK project Study-wide 304 G=0.822 A=0.178
Qatari Global Study-wide 216 G=0.926 A=0.074
SGDP_PRJ Global Study-wide 88 G=0.48 A=0.52
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 64 G=0.66 A=0.34
Siberian Global Study-wide 10 G=0.5 A=0.5
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 11 NC_000011.10:g.89284793G>A
GRCh37.p13 chr 11 NC_000011.9:g.89017961G>A
TYR RefSeqGene NG_008748.1:g.111922G>A
Gene: TYR, tyrosinase (plus strand)
Molecule type Change Amino acid[Codon] SO Term
TYR transcript NM_000372.5:c.1205G>A R [CGA] > Q [CAA] Coding Sequence Variant
tyrosinase precursor NP_000363.1:p.Arg402Gln R (Arg) > Q (Gln) Missense Variant
TYR transcript variant X1 XM_011542970.3:c.1205G>A R [CGA] > Q [CAA] Coding Sequence Variant
tyrosinase isoform X1 XP_011541272.1:p.Arg402Gln R (Arg) > Q (Gln) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: A (allele ID: 18818 )
ClinVar Accession Disease Names Clinical Significance
RCV000003978.12 Oculocutaneous albinism type 1B Conflicting-Interpretations-Of-Pathogenicity
RCV000003979.7 Temperature-sensitive oculocutaneous albinism type 1 Pathogenic
RCV000003980.7 Melanoma, cutaneous malignant, susceptibility to, 8 Risk-Factor
RCV000003981.7 Skin/hair/eye pigmentation, variation in, 3 Association
RCV000003982.7 Skin/hair/eye pigmentation 3, blue/green eyes Association
RCV000085910.12 not provided Conflicting-Interpretations-Of-Pathogenicity,Other
RCV000254054.4 not specified Benign
RCV000379382.4 Oculocutaneous albinism Likely-Benign
RCV000500466.12 Tyrosinase-negative oculocutaneous albinism Conflicting-Interpretations-Of-Pathogenicity
RCV000626673.2 Abnormality of metabolism/homeostasis,Albinism,Choroidal neovascularization,Elevated hepatic transaminase,Foveal hypoplasia,Slow decrease in visual acuity Likely-Pathogenic
RCV000721172.2 Autosomal recessive ocular albinism Other
RCV001269379.2 Malignant tumor of breast Likely-Benign
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement G= A
GRCh38.p14 chr 11 NC_000011.10:g.89284793= NC_000011.10:g.89284793G>A
GRCh37.p13 chr 11 NC_000011.9:g.89017961= NC_000011.9:g.89017961G>A
TYR RefSeqGene NG_008748.1:g.111922= NG_008748.1:g.111922G>A
TYR transcript NM_000372.5:c.1205= NM_000372.5:c.1205G>A
TYR transcript NM_000372.4:c.1205= NM_000372.4:c.1205G>A
TYR transcript variant X1 XM_011542970.3:c.1205= XM_011542970.3:c.1205G>A
TYR transcript variant X1 XM_011542970.2:c.1205= XM_011542970.2:c.1205G>A
TYR transcript variant X1 XM_011542970.1:c.1205= XM_011542970.1:c.1205G>A
tyrosinase precursor NP_000363.1:p.Arg402= NP_000363.1:p.Arg402Gln
tyrosinase isoform X1 XP_011541272.1:p.Arg402= XP_011541272.1:p.Arg402Gln
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

94 SubSNP, 22 Frequency, 12 ClinVar submissions
No Submitter Submission ID Date (Build)
1 PERLEGEN ss24409602 Sep 20, 2004 (126)
2 ABI ss39943701 Mar 11, 2006 (126)
3 SNP500CANCER ss48297598 Mar 11, 2006 (126)
4 HUMANGENOME_JCVI ss97497134 Feb 05, 2009 (130)
5 ENSEMBL ss132039354 Dec 01, 2009 (131)
6 SEATTLESEQ ss159724522 Dec 01, 2009 (131)
7 1000GENOMES ss235654937 Jul 15, 2010 (132)
8 OMICIA ss244239056 May 27, 2010 (132)
9 BL ss255326073 May 09, 2011 (134)
10 OMIM-CURATED-RECORDS ss262857361 Sep 17, 2010 (132)
11 GMI ss286425988 Apr 25, 2013 (138)
12 NHLBI-ESP ss342337937 May 09, 2011 (134)
13 1000GENOMES ss491026892 May 04, 2012 (137)
14 EXOME_CHIP ss491457252 May 04, 2012 (137)
15 CLINSEQ_SNP ss491651950 May 04, 2012 (137)
16 RISN-LSDB ss562055715 Dec 21, 2012 (137)
17 SSMP ss658239502 Apr 25, 2013 (138)
18 ILLUMINA ss780902535 Sep 08, 2015 (146)
19 ILLUMINA ss783589725 Sep 08, 2015 (146)
20 EVA-GONL ss988794005 Aug 21, 2014 (142)
21 JMKIDD_LAB ss1067527102 Aug 21, 2014 (142)
22 JMKIDD_LAB ss1077919510 Aug 21, 2014 (142)
23 1000GENOMES ss1342329583 Aug 21, 2014 (142)
24 HAMMER_LAB ss1397612469 Sep 08, 2015 (146)
25 DDI ss1426708619 Apr 01, 2015 (144)
26 EVA_FINRISK ss1584077365 Apr 01, 2015 (144)
27 EVA_DECODE ss1598457132 Apr 01, 2015 (144)
28 EVA_UK10K_ALSPAC ss1627130758 Apr 01, 2015 (144)
29 EVA_UK10K_TWINSUK ss1670124791 Apr 01, 2015 (144)
30 EVA_EXAC ss1690580647 Apr 01, 2015 (144)
31 EVA_MGP ss1711304832 Apr 01, 2015 (144)
32 ILLUMINA ss1752037676 Sep 08, 2015 (146)
33 ILLUMINA ss1917864817 Feb 12, 2016 (147)
34 WEILL_CORNELL_DGM ss1932153251 Feb 12, 2016 (147)
35 ILLUMINA ss1946318729 Feb 12, 2016 (147)
36 ILLUMINA ss1959373726 Feb 12, 2016 (147)
37 JJLAB ss2026819437 Sep 14, 2016 (149)
38 USC_VALOUEV ss2155131302 Dec 20, 2016 (150)
39 GNOMAD ss2739304950 Nov 08, 2017 (151)
40 GNOMAD ss2748714489 Nov 08, 2017 (151)
41 GNOMAD ss2902657370 Nov 08, 2017 (151)
42 AFFY ss2984952704 Nov 08, 2017 (151)
43 AFFY ss2985595468 Nov 08, 2017 (151)
44 SWEGEN ss3008520893 Nov 08, 2017 (151)
45 ILLUMINA ss3021362316 Nov 08, 2017 (151)
46 CSHL ss3349717827 Nov 08, 2017 (151)
47 ILLUMINA ss3626713834 Oct 12, 2018 (152)
48 ILLUMINA ss3634468188 Oct 12, 2018 (152)
49 ILLUMINA ss3640175527 Oct 12, 2018 (152)
50 ILLUMINA ss3644571574 Oct 12, 2018 (152)
51 OMUKHERJEE_ADBS ss3646431085 Oct 12, 2018 (152)
52 URBANLAB ss3649665519 Oct 12, 2018 (152)
53 ILLUMINA ss3651728807 Oct 12, 2018 (152)
54 ILLUMINA ss3653725047 Oct 12, 2018 (152)
55 EVA_DECODE ss3692296988 Jul 13, 2019 (153)
56 ACPOP ss3738400409 Jul 13, 2019 (153)
57 ILLUMINA ss3744385771 Jul 13, 2019 (153)
58 ILLUMINA ss3744769008 Jul 13, 2019 (153)
59 EVA ss3749617169 Jul 13, 2019 (153)
60 ILLUMINA ss3772268806 Jul 13, 2019 (153)
61 KHV_HUMAN_GENOMES ss3814948979 Jul 13, 2019 (153)
62 EVA ss3824660861 Apr 26, 2020 (154)
63 EVA ss3825806860 Apr 26, 2020 (154)
64 EVA ss3832756621 Apr 26, 2020 (154)
65 EVA ss3839936534 Apr 26, 2020 (154)
66 EVA ss3845417286 Apr 26, 2020 (154)
67 SGDP_PRJ ss3876802526 Apr 26, 2020 (154)
68 KRGDB ss3925231316 Apr 26, 2020 (154)
69 FSA-LAB ss3984010763 Apr 26, 2021 (155)
70 EVA ss3984654698 Apr 26, 2021 (155)
71 EVA ss3985547796 Apr 26, 2021 (155)
72 EVA ss3986540921 Apr 26, 2021 (155)
73 TOPMED ss4894428885 Apr 26, 2021 (155)
74 EVA ss5236898534 Apr 26, 2021 (155)
75 EVA ss5237216183 Apr 26, 2021 (155)
76 EVA ss5237498577 Apr 26, 2021 (155)
77 EVA ss5237658253 Oct 16, 2022 (156)
78 1000G_HIGH_COVERAGE ss5288346877 Oct 16, 2022 (156)
79 EVA ss5315563653 Oct 16, 2022 (156)
80 EVA ss5401236915 Oct 16, 2022 (156)
81 HUGCELL_USP ss5483405007 Oct 16, 2022 (156)
82 1000G_HIGH_COVERAGE ss5584533369 Oct 16, 2022 (156)
83 EVA ss5623954773 Oct 16, 2022 (156)
84 EVA ss5624024416 Oct 16, 2022 (156)
85 SANFORD_IMAGENETICS ss5651748407 Oct 16, 2022 (156)
86 TOMMO_GENOMICS ss5751430138 Oct 16, 2022 (156)
87 EVA ss5799444886 Oct 16, 2022 (156)
88 EVA ss5837012872 Oct 16, 2022 (156)
89 EVA ss5847395170 Oct 16, 2022 (156)
90 EVA ss5847642961 Oct 16, 2022 (156)
91 EVA ss5848334229 Oct 16, 2022 (156)
92 EVA ss5921024389 Oct 16, 2022 (156)
93 EVA ss5943070593 Oct 16, 2022 (156)
94 EVA ss5979366829 Oct 16, 2022 (156)
95 1000Genomes NC_000011.9 - 89017961 Oct 12, 2018 (152)
96 1000Genomes_30x NC_000011.10 - 89284793 Oct 16, 2022 (156)
97 The Avon Longitudinal Study of Parents and Children NC_000011.9 - 89017961 Oct 12, 2018 (152)
98 Genome-wide autozygosity in Daghestan NC_000011.8 - 88657609 Apr 26, 2020 (154)
99 ExAC NC_000011.9 - 89017961 Oct 12, 2018 (152)
100 FINRISK NC_000011.9 - 89017961 Apr 26, 2020 (154)
101 gnomAD - Genomes NC_000011.10 - 89284793 Apr 26, 2021 (155)
102 gnomAD - Exomes NC_000011.9 - 89017961 Jul 13, 2019 (153)
103 Genome of the Netherlands Release 5 NC_000011.9 - 89017961 Apr 26, 2020 (154)
104 HapMap NC_000011.10 - 89284793 Apr 26, 2020 (154)
105 KOREAN population from KRGDB NC_000011.9 - 89017961 Apr 26, 2020 (154)
106 Medical Genome Project healthy controls from Spanish population NC_000011.9 - 89017961 Apr 26, 2020 (154)
107 Northern Sweden NC_000011.9 - 89017961 Jul 13, 2019 (153)
108 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000011.9 - 89017961 Apr 26, 2021 (155)
109 CNV burdens in cranial meningiomas NC_000011.9 - 89017961 Apr 26, 2021 (155)
110 Qatari NC_000011.9 - 89017961 Apr 26, 2020 (154)
111 SGDP_PRJ NC_000011.9 - 89017961 Apr 26, 2020 (154)
112 Siberian NC_000011.9 - 89017961 Apr 26, 2020 (154)
113 14KJPN NC_000011.10 - 89284793 Oct 16, 2022 (156)
114 TopMed NC_000011.10 - 89284793 Apr 26, 2021 (155)
115 UK 10K study - Twins NC_000011.9 - 89017961 Oct 12, 2018 (152)
116 ALFA NC_000011.10 - 89284793 Apr 26, 2021 (155)
117 ClinVar RCV000003978.12 Oct 16, 2022 (156)
118 ClinVar RCV000003979.7 Oct 16, 2022 (156)
119 ClinVar RCV000003980.7 Oct 16, 2022 (156)
120 ClinVar RCV000003981.7 Oct 16, 2022 (156)
121 ClinVar RCV000003982.7 Oct 16, 2022 (156)
122 ClinVar RCV000085910.12 Oct 16, 2022 (156)
123 ClinVar RCV000254054.4 Oct 16, 2022 (156)
124 ClinVar RCV000379382.4 Oct 16, 2022 (156)
125 ClinVar RCV000500466.12 Oct 16, 2022 (156)
126 ClinVar RCV000626673.2 Oct 16, 2022 (156)
127 ClinVar RCV000721172.2 Oct 16, 2022 (156)
128 ClinVar RCV001269379.2 Oct 16, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs1800422 Mar 11, 2006 (126)
rs3182064 Oct 09, 2002 (108)
rs17192517 Oct 08, 2004 (123)
rs17415673 May 11, 2012 (137)
rs62645918 Nov 20, 2012 (136)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
83622, ss255326073, ss286425988, ss491651950, ss1397612469, ss1598457132 NC_000011.8:88657608:G:A NC_000011.10:89284792:G:A (self)
54888054, 30467451, 851954, 73826, 8521915, 13594826, 32408710, 420592, 11685274, 773723, 204180, 14195181, 28819506, 7647656, 30467451, ss235654937, ss342337937, ss491026892, ss491457252, ss658239502, ss780902535, ss783589725, ss988794005, ss1067527102, ss1077919510, ss1342329583, ss1426708619, ss1584077365, ss1627130758, ss1670124791, ss1690580647, ss1711304832, ss1752037676, ss1917864817, ss1932153251, ss1946318729, ss1959373726, ss2026819437, ss2155131302, ss2739304950, ss2748714489, ss2902657370, ss2984952704, ss2985595468, ss3008520893, ss3021362316, ss3349717827, ss3626713834, ss3634468188, ss3640175527, ss3644571574, ss3646431085, ss3651728807, ss3653725047, ss3738400409, ss3744385771, ss3744769008, ss3749617169, ss3772268806, ss3824660861, ss3825806860, ss3832756621, ss3839936534, ss3876802526, ss3925231316, ss3984010763, ss3984654698, ss3985547796, ss3986540921, ss5237498577, ss5315563653, ss5401236915, ss5623954773, ss5624024416, ss5651748407, ss5799444886, ss5837012872, ss5847395170, ss5847642961, ss5848334229, ss5943070593, ss5979366829 NC_000011.9:89017960:G:A NC_000011.10:89284792:G:A (self)
RCV000003978.12, RCV000003979.7, RCV000003980.7, RCV000003981.7, RCV000003982.7, RCV000085910.12, RCV000254054.4, RCV000379382.4, RCV000500466.12, RCV000626673.2, RCV000721172.2, RCV001269379.2, 72059304, 387377926, 661493, 85267242, 109974541, 13848930718, ss244239056, ss262857361, ss562055715, ss3649665519, ss3692296988, ss3814948979, ss3845417286, ss4894428885, ss5236898534, ss5237216183, ss5237658253, ss5288346877, ss5483405007, ss5584533369, ss5751430138, ss5921024389 NC_000011.10:89284792:G:A NC_000011.10:89284792:G:A (self)
ss24409602, ss39943701, ss48297598, ss97497134, ss132039354, ss159724522 NT_167190.1:34323755:G:A NC_000011.10:89284792:G:A (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

47 citations for rs1126809
PMID Title Author Year Journal
666627 Heterogeneity in Waardenburg's syndrome. Report of a family with ocular albinism. Bard LA et al. 1978 Archives of ophthalmology (Chicago, Ill.
1429711 Mutational mapping of the catalytic activities of human tyrosinase. Tripathi RK et al. 1992 The Journal of biological chemistry
1820207 A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity. Tripathi RK et al. 1991 Gene expression
1900307 Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism. King RA et al. 1991 The Journal of clinical investigation
7704033 Autosomal recessive ocular albinism associated with a functionally significant tyrosinase gene polymorphism. Fukai K et al. 1995 Nature genetics
9158138 Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA). Morell R et al. 1997 Human molecular genetics
10766867 A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature. Berson JF et al. 2000 The Journal of biological chemistry
17952075 Genetic determinants of hair, eye and skin pigmentation in Europeans. Sulem P et al. 2007 Nature genetics
18326704 A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients. Hutton SM et al. 2008 Investigative ophthalmology & visual science
18488027 ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Gudbjartsson DF et al. 2008 Nature genetics
18488028 Two newly identified genetic determinants of pigmentation in Europeans. Sulem P et al. 2008 Nature genetics
18925668 A new hypothesis of OCA1B. Chiang PW et al. 2008 American journal of medical genetics. Part A
19208379 The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism. Oetting WS et al. 2009 American journal of medical genetics. Part A
19320745 Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients. Council ML et al. 2009 Experimental dermatology
19340012 Genome-wide association study of tanning phenotype in a population of European ancestry. Nan H et al. 2009 The Journal of investigative dermatology
19384953 Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Nan H et al. 2009 International journal of cancer
19533789 Oculocutaneous albinism spectrum. Chiang PW et al. 2009 American journal of medical genetics. Part A
19578364 Genome-wide association study identifies three loci associated with melanoma risk. Bishop DT et al. 2009 Nature genetics
19710684 Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. Duffy DL et al. 2010 The Journal of investigative dermatology
19863770 Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: lessons from genome-wide association studies. Udayakumar D et al. 2009 Genome medicine
20301345 Oculocutaneous Albinism Type 1 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. Lewis RA et al. 1993 GeneReviews(®)
20410501 Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. Jin Y et al. 2010 The New England journal of medicine
20546537 Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis. Gerstenblith MR et al. 2010 Pigment cell & melanoma research
20585100 Genome-wide association studies of cancer. Stadler ZK et al. 2010 Journal of clinical oncology
21221757 ASIP genetic variants and the number of non-melanoma skin cancers. Lin W et al. 2011 Cancer causes & control
21541274 Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism. Preising MN et al. 2011 Molecular vision
23110848 Human pigmentation genes under environmental selection. Sturm RA et al. 2012 Genome biology
23504663 DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics. Simeonov DR et al. 2013 Human mutation
24809478 Implications of the admixture process in skin color molecular assessment. Cerqueira CC et al. 2014 PloS one
25077817 Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. Barrett JH et al. 2015 International journal of cancer
25216246 Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1). Ghodsinejad Kalahroudi V et al. 2014 PloS one
25741868 Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Richards S et al. 2015 Genetics in medicine
26870082 Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci. Shen C et al. 2016 Frontiers in genetics
27079684 Genome-wide association studies and epigenome-wide association studies go together in cancer control. Verma M et al. 2016 Future oncology (London, England)
27424798 Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma. Chahal HS et al. 2016 Nature communications
27539887 Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma. Chahal HS et al. 2016 Nature communications
27716216 The Anatomy to Genomics (ATG) Start Genetics medical school initiative: incorporating exome sequencing data from cadavers used for Anatomy instruction into the first year curriculum. Gerhard GS et al. 2016 BMC medical genomics
29518100 Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels. Nair-Shalliker V et al. 2018 PloS one
30680790 Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients. Rayner JE et al. 2019 Journal of the European Academy of Dermatology and Venereology
32915910 Association between brown eye colour in rs12913832:GG individuals and SNPs in TYR, TYRP1, and SLC24A4. Meyer OS et al. 2020 PloS one
33167923 Skin pigmentation polymorphisms associated with increased risk of melanoma in a case-control sample from southern Brazil. Reis LB et al. 2020 BMC cancer
33692100 Genome-wide association study in almost 195,000 individuals identifies 50 previously unidentified genetic loci for eye color. Simcoe M et al. 2021 Science advances
34071952 Prediction of Eye Colour in Scandinavians Using the EyeColour 11 (EC11) SNP Set. Meyer OS et al. 2021 Genes
34238381 Association of pigmentation related-genes polymorphisms and geographic environmental variables in the Chinese population. Wang Y et al. 2021 Hereditas
34373545 Pathogenic nsSNPs that increase the risks of cancers among the Orang Asli and Malays. Khoruddin NA et al. 2021 Scientific reports
35803923 The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism. Michaud V et al. 2022 Nature communications
35933957 Generation of a human induced pluripotent stem cell line carrying the TYR c.575C>A (p.Ser192Tyr) and c.1205G>A (p.Arg402Gln) variants in homozygous state using CRISPR-Cas9 genome editing. Liu J et al. 2022 Stem cell research
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post761+d5e8e07